Figure 8: Percentage of the Effective Period before and after FDA Approval for NIH Licenses Associated with FDA-Approved Drugs

Uploaded by U.S. Government Accountability Office
License United States Government Work
Comments 0
Favorites 0
Views 2,825
Date uploaded 2021-02-01
Tags gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao2152, biomedicalresearch, anda, abbreviatednewdrugapplication, cdc, centersfordiseasecontrolandprevention, crada, cooperativeresearchanddevelopmentagreement, departmentofcommerce, covid19, coronavirusdisease2019, doj, departmentofjustice, fda, foodanddrugadministration, ftc, federaltradecommission, hhs, departmentofhealthandhumanservices, ipc, internationalpatentclassification, nih, nationalinstitutesofhealth, nist, nationalinstituteofstandardsandtechnology, phrma, pharmaceuticalresearchandmanufacturersofamerica, prep, preexposureprophylaxis, rd, researchanddevelopment, uspto, unitedstatespatentandtrademarkoffice
Visibility public